TFRC and acute lymphoblastic leukemia: Data showed that TfR-CAR T cells were powerfully potent in killing all these types of cells in vitro and in killing T-ALL cells in vivo, suggesting TfR to be a universal target to broaden and improve the therapeutic efficacy of CAR-modified cells.